Zealand Pharma Announces Share Capital Increase

MT Newswires Live03-20

Zealand Pharma (ZEAL) said late Thursday its board has decided to increase its share capital by a nominal amount of 10,530 Danish Krone ($1633.3) divided into 10,530 new shares with a nominal value of 1 Danish Krone each.

The capital increase follows the exercise of warrants granted under one of its employee warrant programs, the company said.

The exercise price was 90.70 Danish Krone per share for 10,530 new shares. The total proceeds to Zealand Pharma from the capital increase amount to 955,071 Danish Krone, the company added.

The new shares allow dividend and other rights from the time of the respective warrant holder's exercise notice. Each new share is eligible for one vote at general meetings, according to the company.

After registering the capital increase with the Danish Business Authority, the company said its share capital will be about 71.5 million Danish Krone divided into 71.5 million shares, corresponding to a total of 71.5 million votes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2620271787?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-20 05:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620271787","market":"fut","top_or_hot":-1,"title":"Zealand Pharma Announces Share Capital Increase","media":"MT Newswires Live","content":"<html><body><p> Zealand Pharma (ZEAL) said late Thursday its board has decided to increase its share capital by a nominal amount of 10,530 Danish Krone ($1633.3) divided into 10,530 new shares with a nominal value of 1 Danish Krone each.</p><p>The capital increase follows the exercise of warrants granted under one of its employee warrant programs, the company said.</p><p>The exercise price was 90.70 Danish Krone per share for 10,530 new shares. The total proceeds to Zealand Pharma from the capital increase amount to 955,071 Danish Krone, the company added.</p><p>The new shares allow dividend and other rights from the time of the respective warrant holder's exercise notice. Each new share is eligible for one vote at general meetings, according to the company.</p><p>After registering the capital increase with the Danish Business Authority, the company said its share capital will be about 71.5 million Danish Krone divided into 71.5 million shares, corresponding to a total of 71.5 million votes.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zealand Pharma Announces Share Capital Increase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZealand Pharma Announces Share Capital Increase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-20 05:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Zealand Pharma (ZEAL) said late Thursday its board has decided to increase its share capital by a nominal amount of 10,530 Danish Krone ($1633.3) divided into 10,530 new shares with a nominal value of 1 Danish Krone each.</p><p>The capital increase follows the exercise of warrants granted under one of its employee warrant programs, the company said.</p><p>The exercise price was 90.70 Danish Krone per share for 10,530 new shares. The total proceeds to Zealand Pharma from the capital increase amount to 955,071 Danish Krone, the company added.</p><p>The new shares allow dividend and other rights from the time of the respective warrant holder's exercise notice. Each new share is eligible for one vote at general meetings, according to the company.</p><p>After registering the capital increase with the Danish Business Authority, the company said its share capital will be about 71.5 million Danish Krone divided into 71.5 million shares, corresponding to a total of 71.5 million votes.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2620271787","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620271787","pubTimestamp":1773955321,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Zealand Pharma  said late Thursday its board has decided to increase its share capital by a nominal amount of 10,530 Danish Krone  divided into 10,530 new shares with a nominal value of 1 Danish Krone each.The capital increase follows the exercise of warrants granted under one of its employee warrant programs, the company said.The exercise price was 90.70 Danish Krone per share for 10,530 new shares. The total proceeds to Zealand Pharma from the capital increase amount to 955,071 Danish Krone, the company added.The new shares allow dividend and other rights from the time of the respective warrant holder's exercise notice. Each new share is eligible for one vote at general meetings, according to the company.After registering the capital increase with the Danish Business Authority, the company said its share capital will be about 71.5 million Danish Krone divided into 71.5 million shares, corresponding to a total of 71.5 million votes.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ZEAL":"Zealand Pharma A/S"},"translate_title":"新西兰制药宣布增资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZEAL":1},"content_text":"Zealand Pharma (ZEAL) said late Thursday its board has decided to increase its share capital by a nominal amount of 10,530 Danish Krone ($1633.3) divided into 10,530 new shares with a nominal value of 1 Danish Krone each.The capital increase follows the exercise of warrants granted under one of its employee warrant programs, the company said.The exercise price was 90.70 Danish Krone per share for 10,530 new shares. The total proceeds to Zealand Pharma from the capital increase amount to 955,071 Danish Krone, the company added.The new shares allow dividend and other rights from the time of the respective warrant holder's exercise notice. Each new share is eligible for one vote at general meetings, according to the company.After registering the capital increase with the Danish Business Authority, the company said its share capital will be about 71.5 million Danish Krone divided into 71.5 million shares, corresponding to a total of 71.5 million votes.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2620271787","isCrawlerRequest":true}